GridAI Technologies (GRDX) Short term Debt (2015 - 2026)
GridAI Technologies' (GRDX) quarterly Short term Debt came in at $6.2 million in Q2 2026, up 792.86% on a YoY basis from $700000.0 in Q2 2025, and little changed quarter-over-quarter from $6.2 million in Q4 2025.
Powered by 
Analysis
GridAI Technologies (GRDX) Short term Debt (2015 - 2026) Analysis & Trends
GridAI Technologies (GRDX) has reported Short term Debt for 8 consecutive years, with $6.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Short term Debt rose 792.86% year-over-year to $6.2 million; the trailing twelve-month figure through Jun 2026 stood at $6.2 million (up 792.86% YoY), and the FY2025 full-year result was $6.2 million, changed N/A from the prior year.
- Short term Debt steadied at $6.2 million in Q2 2026 per GRDX's latest filing, from $6.2 million in the prior quarter.
- Across five years, Short term Debt topped out at $6.2 million in Q4 2025 and bottomed at $700000.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | GridAI Technologies | 19.07 Mn | 19.07 Mn | -36,514.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.25 Mn |
| Dec 31, 2025 | 6.25 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 700,000.00 |
| Mar 31, 2025 | 700,000.00 |
| Sep 30, 2020 | 38,453.00 |
| Jun 30, 2020 | 396,853.00 |
| Mar 31, 2020 | 396,853.00 |
| Dec 31, 2019 | 1.08 Mn |
| Sep 30, 2019 | 525,520.00 |
| Jun 30, 2019 | 627,563.00 |
| Mar 31, 2019 | 643,428.00 |
| Dec 31, 2018 | 670,095.00 |
| Sep 30, 2018 | 639,635.00 |
| Jun 30, 2018 | 1.04 Mn |
| Mar 31, 2018 | 699,411.00 |
| Dec 31, 2017 | 868,105.00 |
| Sep 30, 2017 | 854,231.00 |
| Jun 30, 2017 | 857,888.00 |
| Mar 31, 2017 | 870,931.00 |